Read more about Glaxosmithkline Pharma gains after turnaround Q3 numbers on Business Standard. Glaxosmithkline Pharmaceuticals rose 3.39% to Rs 1,480 after the company reported consolidated net profit at Rs 156.51 crore in Q3 December 2020 compared with net loss of Rs 661.16 crore in Q3 December 2019.